RecruitingNot ApplicableNCT05396638

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents


Sponsor

University of Colorado, Denver

Enrollment

30 participants

Start Date

Oct 13, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This project seeks to learn more about the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents to address a fundamental gap in knowledge and identify biomarkers that may help distinguish youth who relapse from youth who remain sober.


Eligibility

Min Age: 14 YearsMax Age: 25 Years

Inclusion Criteria2

  • 14 to 25 years of age.
  • Use cannabis at least twice a week for the past month.

Exclusion Criteria9

  • Refusal of valid written consent,
  • Current psychosis,
  • Obvious intoxication,
  • Current risk of suicide,
  • Violence sufficiently great to interfere with evaluation or to endanger evaluators,
  • Obvious intellectual deficiency as noted during the informed consent process, or inability of patient or family to comply with the study protocol.
  • Use of other illicit drugs in the past 90 days by self-report or detected by urine drug test.
  • Use of opioid medications for medical or recreational purposes currently or within the past 90 days.
  • Does not have access to an Internet connected devise or cannot use Zoom.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALContingency Management

Participants will be paid for abstinence at each study visit.


Locations(1)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05396638


Related Trials